Agreements reached under this partnership
Business alliance- 1
Promotion of stronger logistics for manufacturers and clinical trials, and the provision of one-stop services for pharmaceutical distribution
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
Immaterial at present. Over the medium to long term, the alliance is expected to contribute to an increase in the corporate value of the Toho Holdings Group.
| Item | Details |
|---|---|
| Name of alliance partner | DHL Supply Chain Japan, Inc. |
| Alliance partner's business activities | A member of the DHL Group, a global leader in the contract logistics industry. The DHL Group provides logistics services including domestic and international small-parcel delivery, e-commerce delivery and fulfillment services, international express delivery, ground, air and ocean transportation, and industry-specific supply chain management. |
| Alliance partner's location | Tokyo Metropolitan Government |
| Type of alliance | Business alliance |
| Details of the alliance | Promotion of stronger logistics for manufacturers and clinical trials, and the provision of one-stop services for pharmaceutical distribution |
| Alliance start date | Discussions will begin (specific date: Not disclosed) |
| Impact on Business Performance | Immaterial at present. Over the medium to long term, the alliance is expected to contribute to an increase in the corporate value of the Toho Holdings Group. |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To combine the DHL Group’s global logistics network and specialized solutions in the life sciences and healthcare sectors with the Toho Group’s pharmaceutical distribution network, thereby strengthening logistics for manufacturers and clinical trials and promoting one-stop services for pharmaceutical distribution.